An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
NCT00097565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2740
Last updated 2017-03-23
Summary
This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.
Conditions
- Lymphoma, Non Hodgkin
Sponsors & Collaborators
-
Genentech, Inc.
lead INDUSTRY
Principal Investigators
-
Cinical Trials · Genentech, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
More Related Trials
-
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
NCT00036426 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573 ·Status: RECRUITING ·Phase: NA
-
Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT00301795 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
NCT00051025 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
NCT00227695 ·Status: COMPLETED ·Phase: PHASE3
-
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
NCT01130194 ·Status: COMPLETED ·Phase: PHASE2
-
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
NCT00136552 ·Status: COMPLETED ·Phase: PHASE3
-
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
NCT00487513 ·Status: COMPLETED
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
NCT06510361 ·Status: RECRUITING ·Phase: PHASE2
-
DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701
NCT01057459 ·Status: COMPLETED
-
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
NCT01829568 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
NCT02927756 ·Status: UNKNOWN
-
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
NCT05284825 ·Status: UNKNOWN ·Phase: NA
-
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
NCT00896519 ·Status: UNKNOWN ·Phase: PHASE2
-
Odronextamab in Low Tumor Volume Advanced FL
NCT07128641 ·Status: RECRUITING ·Phase: PHASE2
-
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT02856646 ·Status: COMPLETED
-
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma
NCT01609036 ·Status: TERMINATED
-
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
NCT00933127 ·Status: COMPLETED
-
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
NCT00490529 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
NCT00186394 ·Status: COMPLETED ·Phase: PHASE2
-
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
NCT00400907 ·Status: UNKNOWN
-
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 ·Status: COMPLETED
-
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223 ·Status: COMPLETED
-
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
NCT01318317 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2